Kevin O'rourke MD, PhD
About Kevin O'rourke MD, PhD
Kevin O'Rourke, MD, PhD, serves as the Director of Investments and Business Development at Roivant Sciences. He has a diverse background in healthcare and research, with previous roles at notable organizations such as Forbes, Merck, and Dana-Farber Cancer Institute.
Current Role at Roivant Sciences
Kevin O'Rourke serves as the Director of Investments and Business Development at Roivant Sciences. He has held this position since 2023, contributing to the company's strategic initiatives in New York, United States. His role involves overseeing investment opportunities and fostering business development efforts within the organization.
Previous Experience in Healthcare
Prior to his current role, O'Rourke accumulated diverse experience in the healthcare sector. He worked at Roivant Sciences as an Associate and later as a Senior Associate in Investments and Business Development from 2021 to 2023. Additionally, he interned at Merck as a Clinical Research Intern in 2017 and held a position at Dana-Farber Cancer Institute as a Research Technician from 2009 to 2011.
Education and Expertise
O'Rourke holds a Doctor of Medicine (MD) from Joan & Sanford I. Weill Medical College of Cornell University, where he studied from 2011 to 2018. He also earned a Doctor of Philosophy (PhD) in Cancer Biology and Genetics from Weill Cornell Graduate School of Medical Sciences between 2013 and 2017. His undergraduate degree is a Bachelor of Arts in Molecular Biology and Biochemistry from Middlebury College, completed from 2005 to 2009.
Recognition and Accomplishments
In 2017, O'Rourke was recognized in Forbes' 30 Under 30 list in the Healthcare category. This accolade highlights his contributions and potential impact in the healthcare industry at a young age. His career has included various roles that demonstrate his commitment to advancing medical research and business development.
Research and Early Career
O'Rourke began his career with research positions, including a Summer Research Student role at Vermont Genetics Network in 2008 and at Los Alamos National Laboratory. He also interned at Partners Center for Personalized Genetic Medicine in 2007. These early experiences laid the foundation for his expertise in genetics and personalized medicine.